Topiramate: A Jack Of All Trade Drug, But Effective Treatment For None?
As you already know, there is no shortage of newsworthy information that crosses my virtual (and even physical) desk on a daily basis. When combined with my undeniably insatiable curiosity, this usually means that I could spend 25 hours a day and 8 days per week writing, or on the radio talking with a notable … Continue reading
Avandia Scandal Could Almost Turn a Republican Into a Democrat
As I put pen to paper (sorry my age is showing) . . . keystroke to screen, regarding the recent buzz surrounding the FDA’s decision to restrict access to the controversial diabetes drug Avandia, I inadvertently found myself on the liberal side of the street relative to growing suspicion and cynicism about motives in the … Continue reading
Can The Health Care Industry Be Trusted? Tune in and tell us what you think?
Posted by piblogger on February 4, 2011 · Comments Off on Can The Health Care Industry Be Trusted? Tune in and tell us what you think?
Not wanting to pick on GlaxoSmithKline but, a little more than a month later, the pharmaceutical giant announced that it would pay $750 million to settle both criminal and civil suits surrounding it’s sale of an antidepressant which it knew was little more than a placebo, as well as tainted baby ointment. First of all, … Continue reading →
Rate this:
Filed under Commentary/Article, Segment Related Information · Tagged with GlaxoSmithKline, health care industry, Jeff Knott, Johnson & Johnson, Navigating the Healthcare Maze, pharmaceutical industry